Geron Corporation (GERN)

US — Healthcare Sector
Peers: DAWN  RZLT  ARVN  VALN  TYRA  VIR  SVRA  REPL  LENZ  AVBP 

Automate Your Wheel Strategy on GERN

With Tiblio's Option Bot, you can configure your own wheel strategy including GERN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
GERN
Published: February 26, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , Feb. 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
Geron Corporation (GERN) Q4 2024 Earnings Call Transcript
GERN
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

Geron Corporation (NASDAQ:GERN ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Aron Feingold - VP of IR and Corporate Communications John Scarlett - Chairman and CEO Michelle Robertson - EVP and CFO Jim Ziegler - EVP and CCO Joseph Eid - EVP, R&D Faye Feller - EVP and CMO Conference Call Participants Peter Lawson - Barclays Tara Bancroft - TD Cowen Faisal Khurshid - Leerink Partners Greg Harrison - Scotiabank Stephen Willey - Stifel Emily Bodnar - H.C. Wainwright Kalpit Patel - B.

Read More
image for news Geron Corporation (GERN) Q4 2024 Earnings Call Transcript
3 Biotech/Healthcare Names Under $10 I Am Buying Now
ARDX, GERN, MRNA, PSNL, TEM
Published: February 21, 2025 by: Seeking Alpha
Sentiment: Positive

Today, I am highlighting three biotech/healthcare stocks that currently trade under $10 a share after some recent weakness. ! am slowly accumulating each of these names on these dips both straight equity purchases and covered call orders. All have had some recent positive despite the action in the shares and have good longer-term prospects.

Read More
image for news 3 Biotech/Healthcare Names Under $10 I Am Buying Now

About Geron Corporation (GERN)

  • IPO Date 1996-07-31
  • Website https://www.geron.com
  • Industry Biotechnology
  • CEO Harout Semerjian
  • Employees 229
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.